I have recently sent out a letter to many of our colleagues and friends in the Iranian scientific community informing them of the recent addition of AJMB to two of the world\'s largest databases, namely: Scopus and Embase. In case the spectrum of the coverage by these databases are not known to the AJMB readers in Iran, I have decided to provide you with some information about these two databases obtained from the official company website. Scopus (launched in November 2004) is a database of abstracts and citations and covers nearly 18,000 titles from more than 5,000 international publishers, including coverage of 16,500 peer-reviewed journals in the scientific, technical, medical and social sciences as well as fields in arts and humanities. It is owned by Elsevier and searches in Scopus incorporate searches of scientific web pages (435 Million), patent databases (23 Million) from 5 patent offices (US Patent and Trademark Office, European Patent Office, Japan Patent Office, World Intellectual Property Organization and UK Intellectual Property Office), article-in-press from over 3000 journals and full coverage of Medline titles.

Embase or the *Excerpta Medica Database* is a biomedical and pharmacological database produced also by Elsevier and contains over 11 million records from 1947 to the present date. Each record is fully indexed and covers over 5,000 biomedical journals from 70 countries and is available online through a number of database vendors. Embase has a holding of more than 2,000 biomedical titles that are not offered by the Medline. Embase delivers comprehensive, authoritative, and reliable coverage of the most relevant biomedical literature.

Now that AJMB has been recognized as a journal deserving to be included in these databases, it is up to the Iranian scientists to support the AJMB\'s mission of publishing high quality articles in the field of Medical Biotechnology from Iran and worldwide. I continue to look forward to receiving your high quality articles and would appreciate if you could inform and encourage your colleagues to submit their articles to AJMB and enjoy its international exposure among thousands of other medical scientific journals in the world.

*Ali M. Ardekani*

*Editor-in-Chief*
